Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 1
1983 2
1984 1
1986 2
1987 3
1988 2
1989 4
1990 2
1991 4
1992 3
1993 4
1994 7
1995 8
1996 4
1997 3
1998 5
1999 3
2000 13
2001 4
2002 2
2003 3
2004 3
2005 5
2006 8
2007 2
2008 11
2009 10
2010 14
2011 15
2012 14
2013 7
2014 8
2015 10
2016 10
2017 9
2018 12
2019 11
2020 8
2021 7
2022 9
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Results by year

Filters applied: . Clear all
Page 1
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection.
Loupy A, Haas M, Roufosse C, Naesens M, Adam B, Afrouzian M, Akalin E, Alachkar N, Bagnasco S, Becker JU, Cornell LD, Clahsen-van Groningen MC, Demetris AJ, Dragun D, Duong van Huyen JP, Farris AB, Fogo AB, Gibson IW, Glotz D, Gueguen J, Kikic Z, Kozakowski N, Kraus E, Lefaucheur C, Liapis H, Mannon RB, Montgomery RA, Nankivell BJ, Nickeleit V, Nickerson P, Rabant M, Racusen L, Randhawa P, Robin B, Rosales IA, Sapir-Pichhadze R, Schinstock CA, Seron D, Singh HK, Smith RN, Stegall MD, Zeevi A, Solez K, Colvin RB, Mengel M. Loupy A, et al. Among authors: glotz d. Am J Transplant. 2020 Sep;20(9):2318-2331. doi: 10.1111/ajt.15898. Epub 2020 May 28. Am J Transplant. 2020. PMID: 32463180 Free PMC article.
Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study.
Loupy A, Aubert O, Orandi BJ, Naesens M, Bouatou Y, Raynaud M, Divard G, Jackson AM, Viglietti D, Giral M, Kamar N, Thaunat O, Morelon E, Delahousse M, Kuypers D, Hertig A, Rondeau E, Bailly E, Eskandary F, Böhmig G, Gupta G, Glotz D, Legendre C, Montgomery RA, Stegall MD, Empana JP, Jouven X, Segev DL, Lefaucheur C. Loupy A, et al. Among authors: glotz d. BMJ. 2019 Sep 17;366:l4923. doi: 10.1136/bmj.l4923. BMJ. 2019. PMID: 31530561 Free PMC article. Clinical Trial.
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.
Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, Nankivell BJ, Halloran PF, Colvin RB, Akalin E, Alachkar N, Bagnasco S, Bouatou Y, Becker JU, Cornell LD, Duong van Huyen JP, Gibson IW, Kraus ES, Mannon RB, Naesens M, Nickeleit V, Nickerson P, Segev DL, Singh HK, Stegall M, Randhawa P, Racusen L, Solez K, Mengel M. Haas M, et al. Among authors: glotz d. Am J Transplant. 2018 Feb;18(2):293-307. doi: 10.1111/ajt.14625. Epub 2018 Jan 21. Am J Transplant. 2018. PMID: 29243394 Free PMC article.
Surrogate Endpoints for Late Kidney Transplantation Failure.
Naesens M, Budde K, Hilbrands L, Oberbauer R, Bellini MI, Glotz D, Grinyó J, Heemann U, Jochmans I, Pengel L, Reinders M, Schneeberger S, Loupy A. Naesens M, et al. Among authors: glotz d. Transpl Int. 2022 May 20;35:10136. doi: 10.3389/ti.2022.10136. eCollection 2022. Transpl Int. 2022. PMID: 35669974 Free PMC article.
[Antibody-mediated acute rejection].
Lefaucheur C, Nochy D, Glotz D. Lefaucheur C, et al. Among authors: glotz d. Nephrol Ther. 2008 Oct;4 Suppl 3:S188-91. doi: 10.1016/S1769-7255(08)74233-0. Nephrol Ther. 2008. PMID: 19000885 Review. French.
New insights in antibody-mediated rejection.
Gosset C, Lefaucheur C, Glotz D. Gosset C, et al. Among authors: glotz d. Curr Opin Nephrol Hypertens. 2014 Nov;23(6):597-604. doi: 10.1097/MNH.0000000000000069. Curr Opin Nephrol Hypertens. 2014. PMID: 25211610 Review.
Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation.
Seron D, Rabant M, Becker JU, Roufosse C, Bellini MI, Böhmig GA, Budde K, Diekmann F, Glotz D, Hilbrands L, Loupy A, Oberbauer R, Pengel L, Schneeberger S, Naesens M. Seron D, et al. Among authors: glotz d. Transpl Int. 2022 May 20;35:10135. doi: 10.3389/ti.2022.10135. eCollection 2022. Transpl Int. 2022. PMID: 35669975 Free PMC article. Review.
The MHC class I MICA gene is a histocompatibility antigen in kidney transplantation.
Carapito R, Aouadi I, Verniquet M, Untrau M, Pichot A, Beaudrey T, Bassand X, Meyer S, Faucher L, Posson J, Morlon A, Kotova I, Delbos F, Walencik A, Aarnink A, Kennel A, Suberbielle C, Taupin JL, Matern BM, Spierings E, Congy-Jolivet N, Essaydi A, Perrin P, Blancher A, Charron D, Cereb N, Maumy-Bertrand M, Bertrand F, Garrigue V, Pernin V, Weekers L, Naesens M, Kamar N, Legendre C, Glotz D, Caillard S, Ladrière M, Giral M, Anglicheau D, Süsal C, Bahram S. Carapito R, et al. Among authors: glotz d. Nat Med. 2022 May;28(5):989-998. doi: 10.1038/s41591-022-01725-2. Epub 2022 Mar 14. Nat Med. 2022. PMID: 35288692 Free PMC article.
Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation.
Roufosse C, Becker JU, Rabant M, Seron D, Bellini MI, Böhmig GA, Budde K, Diekmann F, Glotz D, Hilbrands L, Loupy A, Oberbauer R, Pengel L, Schneeberger S, Naesens M. Roufosse C, et al. Among authors: glotz d. Transpl Int. 2022 May 20;35:10140. doi: 10.3389/ti.2022.10140. eCollection 2022. Transpl Int. 2022. PMID: 35669973 Free PMC article.
237 results